Psagot Value Holdings Ltd. Bristol Myers Squibb CO Transaction History

Psagot Value Holdings Ltd.

Previous 0 NaN%

Previous $0 NaN%

100.0%

Previous 100.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$39.66 - $51.75 $0 - $0	0 New	0 $0
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $136,769 - $180,060	-3,398 Closed	0 $0
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $1.16 Million - $1.31 Million	-24,150 Reduced 87.67%	3,398 $184,000
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $30,978 - $36,966	-639 Reduced 2.27%	27,548 $1.41 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $985,147 - $1.09 Million	-15,463 Reduced 35.42%	28,187 $1.8 Million
Q1 2023 Jun 20, 2023	SELL	$65.71 - $74.53 $2.2 Million - $2.49 Million	-33,471 Reduced 43.4%	43,650 $2.95 Million
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $462,856 - $548,087	6,759 Added 9.61%	77,121 $5.55 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $3,232 - $1.91 Million	24,862 Added 54.64%	70,362 $5 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $341,749 - $376,385	-4,706 Reduced 9.37%	45,500 $3.5 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $920,355 - $1.1 Million	-14,970 Reduced 22.97%	50,206 $3.67 Million
Q4 2021 Mar 14, 2022	BUY	$53.63 - $62.52 $3.5 Million - $4.07 Million	65,176 New	65,176 $68,000

2,537

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.